D-Index & Metrics Best Publications
Research.com 2022 Best Scientist Award Badge

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 177 Citations 118,248 1,026 World Ranking 140 National Ranking 96
Best Scientists D-index 178 Citations 121,163 1,645 World Ranking 468 National Ranking 314

Research.com Recognitions

Awards & Achievements

2022 - Research.com Best Scientist Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Surgery

His main research concerns Multiple myeloma, Internal medicine, Pathology, Surgery and Amyloidosis. His Monoclonal gammopathy of undetermined significance research extends to Multiple myeloma, which is thematically connected. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Oncology.

His study in Pathology is interdisciplinary in nature, drawing from both Immunoglobulin light chain, Immunofixation, Monoclonal and Macroglobulinemia. In his study, MEDLINE and Disease is inextricably linked to Intensive care medicine, which falls within the broad field of Surgery. His Amyloidosis study combines topics from a wide range of disciplines, such as Heart failure, Cardiology, AL amyloidosis and Primary systemic amyloidosis.

His most cited work include:

  • International uniform response criteria for multiple myeloma (2049 citations)
  • International staging system for multiple myeloma. (1912 citations)
  • Improved survival in multiple myeloma and the impact of novel therapies (1718 citations)

What are the main themes of his work throughout his whole career to date?

Robert A. Kyle spends much of his time researching Internal medicine, Multiple myeloma, Pathology, Gastroenterology and Surgery. His Internal medicine study often links to related topics such as Oncology. His work carried out in the field of Multiple myeloma brings together such families of science as Monoclonal gammopathy of undetermined significance, Monoclonal and Bone marrow.

His Pathology research is multidisciplinary, relying on both Immunofixation and Macroglobulinemia. His Gastroenterology research integrates issues from Survival rate and Myeloma protein. The concepts of his Surgery study are interwoven with issues in Thalidomide and Lenalidomide.

He most often published in these fields:

  • Internal medicine (42.96%)
  • Multiple myeloma (40.58%)
  • Pathology (20.35%)

What were the highlights of his more recent work (between 2013-2021)?

  • Internal medicine (42.96%)
  • Multiple myeloma (40.58%)
  • Oncology (13.09%)

In recent papers he was focusing on the following fields of study:

Robert A. Kyle mostly deals with Internal medicine, Multiple myeloma, Oncology, Gastroenterology and Pathology. His research brings together the fields of Surgery and Internal medicine. His research investigates the connection between Multiple myeloma and topics such as Transplantation that intersect with problems in Stem cell.

His Oncology research incorporates elements of Waldenstrom macroglobulinemia, Hematopoietic stem cell transplantation, Clinical trial, Immunology and Bortezomib. He has researched Gastroenterology in several fields, including Monoclonal gammopathy of undetermined significance, Myeloma protein, Progression-free survival and Lymphoma. His biological study spans a wide range of topics, including Immunoglobulin light chain and Very Good Partial Response.

Between 2013 and 2021, his most popular works were:

  • International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. (1706 citations)
  • International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma (828 citations)
  • Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients (768 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Disease

The scientist’s investigation covers issues in Internal medicine, Multiple myeloma, Gastroenterology, Pathology and Surgery. Internal medicine is frequently linked to Oncology in his study. The Multiple myeloma study combines topics in areas such as Hematology and Monoclonal gammopathy of undetermined significance, Monoclonal.

In his study, which falls under the umbrella issue of Gastroenterology, Stage is strongly linked to Hazard ratio. Robert A. Kyle focuses mostly in the field of Pathology, narrowing it down to topics relating to Monosomy and, in certain cases, Fluorescence in situ hybridization. He combines subjects such as Cohort and Confidence interval with his study of Surgery.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

International uniform response criteria for multiple myeloma

B. G. M. Durie;J.-L. Harousseau;J. S. Miguel;J. Blade.
Leukemia (2006)

2975 Citations

International staging system for multiple myeloma.

Philip R. Greipp;Jesus San Miguel;Brian G.M. Durie;John J. Crowley.
Journal of Clinical Oncology (2005)

2970 Citations

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

S. Vincent Rajkumar;Meletios A. Dimopoulos;Antonio Palumbo;Joan Blade.
Lancet Oncology (2014)

2775 Citations

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

Robert A. Kyle;J. Anthony Child;Kenneth Anderson;Bart Barlogie.
British Journal of Haematology (2003)

2665 Citations

Review of 1027 Patients With Newly Diagnosed Multiple Myeloma

Robert A. Kyle;Morie A. Gertz;Thomas E. Witzig;John A. Lust.
Mayo Clinic Proceedings (2003)

2466 Citations

Improved survival in multiple myeloma and the impact of novel therapies

Shaji K. Kumar;S. Vincent Rajkumar;Angela Dispenzieri;Martha Q. Lacy.
Blood (2008)

2418 Citations

A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

Robert A. Kyle;Terry M. Therneau;S. Vincent Rajkumar;Janice R. Offord.
The New England Journal of Medicine (2002)

1597 Citations

Primary systemic amyloidosis : clinical and laboratory features in 474 cases

Kyle Ra;Gertz Ma.
Seminars in Hematology (1995)

1543 Citations

Drug therapy: Multiple myeloma

Robert A. Kyle;S. Vincent Rajkumar.
The New England Journal of Medicine (2004)

1499 Citations

Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma

R A Kyle;S V Rajkumar.
Leukemia (2009)

1363 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Robert A. Kyle

Meletios A. Dimopoulos

Meletios A. Dimopoulos

National and Kapodistrian University of Athens

Publications: 446

Kenneth C. Anderson

Kenneth C. Anderson

Harvard University

Publications: 373

Morie A. Gertz

Morie A. Gertz

Mayo Clinic

Publications: 363

Angela Dispenzieri

Angela Dispenzieri

Mayo Clinic

Publications: 355

Shaji Kumar

Shaji Kumar

Mayo Clinic

Publications: 351

Paul G. Richardson

Paul G. Richardson

Harvard University

Publications: 339

Philippe Moreau

Philippe Moreau

University of Nantes

Publications: 278

Giampaolo Merlini

Giampaolo Merlini

University of Pavia

Publications: 263

Evangelos Terpos

Evangelos Terpos

National and Kapodistrian University of Athens

Publications: 253

Hartmut Goldschmidt

Hartmut Goldschmidt

University Hospital Heidelberg

Publications: 249

Ola Landgren

Ola Landgren

University of Miami

Publications: 246

Antonio Palumbo

Antonio Palumbo

University of Turin

Publications: 244

Nikhil C. Munshi

Nikhil C. Munshi

Harvard University

Publications: 240

S. Vincent Rajkumar

S. Vincent Rajkumar

Mayo Clinic

Publications: 239

Gareth J. Morgan

Gareth J. Morgan

New York University

Publications: 234

Pieter Sonneveld

Pieter Sonneveld

Erasmus University Rotterdam

Publications: 198

Something went wrong. Please try again later.